SOAPP/COMM

Tools that help predict and monitor patient response to opioid medications, now available online with PainCAS Clinical Assessment System featuring SOAPP and COMM.

SOAPP-8

The Screener and Opioid Assessment for Patients in Pain (SOAPP®) is a brief self-report tool to facilitate assessment and planning for chronic pain patients being considered for long-term opioid treatment.

  • The new electronic SOAPP-8 includes eight items which have been identified as being the strongest predictors of aberrant drug-related behavior.  Importantly, these eight items are able to correctly identify which patients will engage in aberrant medication related behavior with nearly 80% accuracy.  SOAPP-8 maintains the same predictive accuracy while reducing the test length by 67%.

COMM-9

The Current Opioid Misuse Measure (COMM®) is a self-report screener that helps clinicians identify whether a patient, currently on long-term opioid therapy, may be engaging in aberrant opioid-related behavior. In contrast, the Screener and Opioid Assessment for Patients with Pain (SOAPP) is intended to predict which patients, being considered for long-term opioid therapy, may exhibit aberrant medications behaviors in the future. Since the COMM examines current misuse, it is ideal for helping clinicians monitor patients’ risk of aberrant medication-related behaviors over the course of treatment.